Lipotoxicity, another critical driver of NASH, is also attenuated by GLP-1 RAs
Danone created Oikos Fusion yogurt as a one-of-a-kind opportunity to serve GLP-1 users, but skips any reference to an explicit GLP-1 Support claim
The pharmaceutical industry has welcomed a host of therapies and vaccines into this revered club, with indications covering everything from cancer and covid-19 to arthritis and atrial fibrillation. In 1986, 10 years after it was first introduced by Smith Kline & French, sales of peptic ulcer treatment Tagamet (cimetidine) surpassed the $1 billion mark, making it the first drug in history to be classified as a blockbuster.2 Since then, the pharmaceutical industry has welcomed a host of therapies and vaccines into this revered club, with indications covering everything from cancer and covid-19 to arthritis and atrial fibrillation
This matters even more once treatment ends
The research behind these compounds is limited, often small-scale or animal-based, and the real-world impact on GLP-1 and weight loss is modest at best
2) Forced-Choice Training (3 days, 10 trials/day, 1 min/trial): After habituation, mice were randomly assigned to left or right arms as high reward (HR
